• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

114.19 +2.62 (+2.35%)
Delayed Quote Updated: 9:39 AM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119,909
Open 112.96
Bid (Size) 113.85 (100)
Ask (Size) 114.52 (300)
Prev. Close 111.57
Today's Range 112.60 - 116.03
52wk Range 83.46 - 132.60
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Discover the top S&P500 movers in Monday's after-hours session. ↗
October 12, 2026
Via Chartmill
News headline image
Incyte to Report Third Quarter Financial Results
October 08, 2026
From Incyte
Via Business Wire

Performance

52-Week Range 13.9% below 52-week high
114.19
83.4652W Low 132.6052W High
1 Week
107.781W Low 114.051W High

Incyte Corporation - Common Stock (INCY) traded between $83.46 and $132.60 over the past 52 weeks and last traded at $114.19, 13.9% below its 52-week high. Over the past week it ranged between $107.78 and $114.05.

Past 12 Months
+1.3%
-6.5%
-0.8%
+17.6%
+12.6%
+32.8%
1W +$1.44
1M -$8.00
3M -$0.90
6M +$17.09
YTD +$12.77
1Y +$28.23

INCY was +32.8% over the past year, +17.6% over six months, +12.6% year to date, +1.3% in the last week.

12 Months vs Market
INCY
+32.8%
DIA
+11.9%
SPY
+15.7%
QQQ
+20.1%
IWM
+9.5%

Over the past 12 months INCY returned +32.8% versus DIA (Dow) +11.9%, SPY (S&P 500) +15.7%, QQQ (Nasdaq 100) +20.1% and IWM (Russell 2000) +9.5%.

Volume & Liquidity 0.07× 3-mo avg
Today 119,909 3-mo avg 1.6M
1W
1.8M
1M
1.8M
3M
1.6M
6M
1.7M
YTD
1.7M
1Y
1.9M

INCY most recently traded 119,909 shares against a 3-month average daily volume of 1.6M.

More News

Read More
News headline image
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
September 30, 2026
Via StockStory
Topics Artificial Intelligence
Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup ↗
September 30, 2026
Via Chartmill
News headline image
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
September 25, 2026
From Mirum Pharmaceuticals, Inc. and Incyte
Via Business Wire
Incyte (NASDAQ:INCY) Combines Minervini Trend Template Strength With High-Growth Momentum ↗
September 18, 2026
Via Chartmill
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗
September 08, 2026
Via Chartmill
Incyte (NASDAQ:INCY) Passes Minervini Trend and High-Growth Screens, But Setup Demands Patience ↗
August 27, 2026
Via Chartmill
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗
August 17, 2026
Via Chartmill
Discover the top S&P500 movers in Tuesday's pre-market session. ↗
September 22, 2026
Via Chartmill
News headline image
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
September 22, 2026
From Incyte
Via Business Wire
News headline image
Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target ↗
September 19, 2026
Via MarketBeat
News headline image
3 Growth Stocks to Add to Your Roster
September 17, 2026
Via StockStory
Topics Economy
News headline image
1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
September 16, 2026
Via StockStory
Topics Credit Cards
News headline image
Incyte (INCY): 3 Reasons We Love This Stock
September 14, 2026
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Here's How Much $1000 Invested In Incyte 20 Years Ago Would Be Worth Today ↗
September 11, 2026
Via Benzinga
News headline image
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
September 11, 2026
Via StockStory
News headline image
3 Market-Beating Stocks with Competitive Advantages
September 09, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
2 Profitable Stocks with Impressive Fundamentals and 1 We Brush Off
September 04, 2026
Via StockStory
News headline image
Incyte to Present at Upcoming Investor Conferences
September 01, 2026
From Incyte
Via Business Wire
News headline image
Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Years ↗
August 20, 2026
Via Benzinga
News headline image
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 07, 2026
From Incyte Corporation
Via Business Wire
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
July 31, 2026
Via StockStory
Topics Supply Chain
News headline image
Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis
July 29, 2026
From Incyte
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
July 28, 2026
Via Chartmill

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 114.19
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 10/15/26 09:39 AM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 25.40B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 25B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap